Resources Contact Us Home
Method for therapeutically treating abnormal cells expressing a major histocompatibility complex class II antigen using cytolytic inducer T4 cells

Image Number 2 for United States Patent #4861589.

The present invention provides a lymphocyte-mediated immunotherapy for the treatment of human or animal subjects afflicted with abnormal or tumor cells which express a MHC Class II antigen on their surface. The method utilizes inducer T-cell clones or lines having a demonstrable specificity for an identifiable antigen. These T-cells are activated in-vivo to express cytolytic and therapeutic activity against the abnormal or tumor cells in the subject.

  Recently Added Patents
Disk-based storage device having read channel memory that is selectively accessible to disk controller
Image processing apparatus and image processing method
Probe card holding apparatus with probe card engagement structure
System and method for multi-tiered meta-data caching and distribution in a clustered computer environment
Systems and methods for automated institutional processing of payments
Paper product with surface pattern
Scanning projection apparatus with tangential compensation
  Randomly Featured Patents
Powdery molybdenum oxysulfide dithiocarbamate composition, a process for producing same, and a grease composition containing the composition
Process for the treatment of acne vulgaris utilizing retinal
Food supplement formulation
Container with flattened cap
Methods of making glass-crystalline particles including a glass component and a crystalline component
Personal duress security system
Short-flanged sheet material forming and joining
Anti-hack protection to restrict installation of operating systems and other software
Detection of passing magnetic articles with a peak referenced threshold detector
Magnetic recording head and magnetic recording device